دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
Stephen J. Nicholls, MBBS, PhD1; A. Michael Lincoff, MD2; Michelle Garcia, RN, BSN, CCRC2; Dianna Bash, BSN2; Christie M. Ballantyne, MD3; Philip J. Barter, MBBS, PhD4; Michael H. Davidson, MD5; John J. P. Kastelein, MD, PhD6; Wolfgang Koenig, MD7; Darren K. McGuire, MD, MHSc8; Dariush Mozaffarian, MD, DrPH9; Paul M Ridker, MD10; Kausik K. Ray, MBChB, MD, MPhil11; Brian G. Katona, PharmD12; Anders Himmelmann, MD, PhD13; Larrye E. Loss, PharmD, MBA12; Martin Rensfeldt13; Torbj?rn Lundstr?m, MD, PhD13; Rahul Agrawal, MD13; Venu Menon, MD2; Kathy Wolski, MPH2; Steven E. Nissen, MD2
doi : 10.1001/jama.2020.22258
JAMA. 2020;324(22):2268-2280
It remains uncertain whether the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduce cardiovascular risk.
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis
Andrew M. Wilson, MD1,2; Allan B. Clark, PhD1; Tony Cahn, PhD3; Edwin R. Chilvers, PhD4; William Fraser, PhD1,5; Matthew Hammond, MSc6; David M. Livermore, PhD1; Toby M. Maher, PhD5,7,8; Helen Parfrey, PhD9; Ann Marie Swart, MSc6; Susan Stirling, MSc6; David R. Thickett, DM10; Moira Whyte, PhD11; on behalf of the EME-TIPAC team
doi : 10.1001/jama.2020.22960
JAMA. 2020;324(22):2282-2291
Idiopathic pulmonary fibrosis (IPF) has a poor prognosis and limited treatment options. Patients with IPF have altered lung microbiota, with bacterial burden within the lungs associated with mortality; previous studies have suggested benefit with co-trimoxazole (trimethoprim-sulfamethoxazole).
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
Eric J. Lenze, MD1; Caline Mattar, MD2; Charles F. Zorumski, MD1; Angela Stevens, BA1; Julie Schweiger1; Ginger E. Nicol, MD1; J. Philip Miller, AB3; Lei Yang, MPH, MSIS1; Michael Yingling, MS1; Michael S. Avidan, MBBCh4; Angela M. Reiersen, MD, MPE1
doi : 10.1001/jama.2020.22760
JAMA. 2020;324(22):2292-2300
Coronavirus disease 2019 (COVID-19) may lead to serious illness as a result of an excessive immune response. Fluvoxamine may prevent clinical deterioration by stimulating the ?-1 receptor, which regulates cytokine production.
Peripheral Oxygen Saturation in Older Persons Wearing Nonmedical Face Masks in Community Settings
Noel C. Chan, MBBS1; Karen Li1; Jack Hirsh, MD, DSc1
doi : 10.1001/jama.2020.21905
JAMA. 2020;324(22):2323-2324
Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants
Giancarlo Natalucci, MD1; Bea Latal, MD2; Brigitte Koller, RN1; Christoph Rüegger, MD1; Beate Sick, PhD3; Leonhard Held, PhD3; Jean-Claude Fauchère, MD1; for the Swiss EPO Neuroprotection Trial Group
doi : 10.1001/jama.2020.19395
JAMA. 2020;324(22):2324-2327
Managing Asthma in Adolescents and Adults
Michelle M. Cloutier, MD1; Anne E. Dixon, MA, BM, BCh2; Jerry A. Krishnan, MD, PhD3; Robert F. Lemanske Jr, MD4; Wilson Pace, MD5; Michael Schatz, MD, MS6
doi : 10.1001/jama.2020.21974
JAMA. 2020;324(22):2301-2317
Asthma is a major public health problem worldwide and is associated with excess morbidity, mortality, and economic costs associated with lost productivity. The National Asthma Education and Prevention Program has released the 2020 Asthma Guideline Update with updated evidence-based recommendations for treatment of patients with asthma.
A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection
S. Deblina Datta, MD1; Amish Talwar, MD, MPH1; James T. Lee, MD, MSc1,2
doi : 10.1001/jama.2020.22717
JAMA. 2020;324(22):2251-2252
Older Adults and the Mental Health Effects of COVID-19
Ipsit V. Vahia, MD1,2; Dilip V. Jeste, MD3; Charles F. Reynolds III, MD4
doi : 10.1001/jama.2020.21753
JAMA. 2020;324(22):2253-2254
Science Denial and COVID Conspiracy Theories
Bruce L. Miller, MD1
doi : 10.1001/jama.2020.21332
JAMA. 2020;324(22):2255-2256
COVID-19, Decarceration, and the Role of Clinicians, Health Systems, and Payers
Emily A. Wang, MD, MAS1,2; Bruce Western, PhD3; Donald M. Berwick, MD, MPP4
doi : 10.1001/jama.2020.22109
JAMA. 2020;324(22):2257-2258
Improving Care for Heart Failure With Reduced Ejection Fraction—A Potential Polypill-Based Strategy
Anubha Agarwal, MD, MSc1; Clyde W. Yancy, MD, MSc1; Mark D. Huffman, MD, MPH2,3
doi : 10.1001/jama.2020.21395
JAMA. 2020;324(22):2259-2260
Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events
Garima Sharma, MD1; Seth S. Martin, MD, MHS1; Roger S. Blumenthal, MD1
doi : 10.1001/jama.2020.22387
JAMA. 2020;324(22):2262-2264
Evolving Strategies for Long-term Asthma Management
Stephanie Lovinsky-Desir, MD, MS1; George T. O’Connor, MD, MS2,3,4
doi : 10.1001/jama.2020.16895
JAMA. 2020;324(22):2265-2267
Preparing for the 2020-2021 Influenza Season
Timothy M. Uyeki, MD, MPH, MPP1; Jeanne Santoli, MD2; Daniel B. Jernigan, MD, MPH1
doi : 10.1001/jama.2020.21849
JAMA. 2020;324(22):2318-2319
Urinary Magnesium in the Evaluation of Hypomagnesemia
Bryan M. Tucker, DO, MS1; James L. Pirkle Jr, MD2; Rajeev Raghavan, MD1
doi : 10.1001/jama.2020.18400
JAMA. 2020;324(22):2320-2321
Do Omega-3 Fatty Acids Benefit Health?
Gregory Curfman, MD1
doi : 10.1001/jama.2020.22898
JAMA. 2020;324(22):2280-2281
COVID-19 Infection—Preventing Clinical Deterioration
Christopher W. Seymour, MD, MSc1,2; Howard Bauchner, MD3; Robert M. Golub, MD4
doi : 10.1001/jama.2020.21720
JAMA. 2020;324(22):2300
Looking to Long-term Survivors for Improved Pancreatic Cancer Treatment
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.21717
JAMA. 2020;324(22):2242-2244
Four COVID-19 Lessons for Achieving Health Equity
Stuart M. Butler, PhD1
doi : 10.1001/jama.2020.23553
JAMA. 2020;324(22):2245-2246
Supplement Use Is Common Among Children and Adolescents
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.23283
JAMA. 2020;324(22):2248
Pulmonary Fungal Infections Affect Patients With COVID-19
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.22914
JAMA. 2020;324(22):2248
Using Smartwatch Data to Detect COVID-19 Cases Early
Jennifer Abbasi
doi : 10.1001/jama.2020.23696
JAMA. 2020;324(22):2247
Long-acting Cabotegravir Shot Prevents HIV Among Women
Jennifer Abbasi
doi : 10.1001/jama.2020.23330
JAMA. 2020;324(22):2247
Neurodegenerative Dementias Are Differentiated on PET Scans
Jennifer Abbasi
doi : 10.1001/jama.2020.23698
JAMA. 2020;324(22):2247
Let Me Not Be Mad—My Story of Unraveling Minds
Eben S. Schwartz, PhD1
doi : 10.1001/jama.2020.20884
JAMA. 2020;324(22):2240-2241
A Supreme Court’s Pronouncement Against the Fly
doi : 10.1001/jama.2020.21562
JAMA. 2020;324(22):2330
High-risk Groups for Influenza Complications
Timothy M. Uyeki, MD, MPH, MPP1
doi : 10.1001/jama.2020.21869
JAMA. 2020;324(22):2334
Intravenous Acetaminophen in Postoperative Patients
S. Ravi Shankar, MBBS, MD1
doi : 10.1001/jama.2020.21462
JAMA. 2020;324(22):2327
Intravenous Acetaminophen in Postoperative Patients—Reply
Alparslan Turan, MD1; Daniel I. Sessler, MD1
doi : 10.1001/jama.2020.21470
JAMA. 2020;324(22):2327
Coding Errors in Study of Factors Associated With SARS-CoV-2 Antibodies in Health Care Personnel
Karina W. Davidson, PhD, MASc1
doi : 10.1001/jama.2020.20994
JAMA. 2020;324(22):2328
